181 related articles for article (PubMed ID: 32612183)
1. An in vitro methodology for discovering broadly-neutralizing monoclonal antibodies.
Ahmadi S; Pucca MB; Jürgensen JA; Janke R; Ledsgaard L; Schoof EM; Sørensen CV; Çalışkan F; Laustsen AH
Sci Rep; 2020 Jul; 10(1):10765. PubMed ID: 32612183
[TBL] [Abstract][Full Text] [Related]
2. Sequential antigen panning for selection of broadly cross-reactive HIV-1-neutralizing human monoclonal antibodies.
Zhang MY; Dimitrov DS
Methods Mol Biol; 2009; 562():143-54. PubMed ID: 19554293
[TBL] [Abstract][Full Text] [Related]
3. Cross-reactive HIV-1 neutralizing monoclonal antibodies selected by screening of an immune human phage library against an envelope glycoprotein (gp140) isolated from a patient (R2) with broadly HIV-1 neutralizing antibodies.
Choudhry V; Zhang MY; Sidorov IA; Louis JM; Harris I; Dimitrov AS; Bouma P; Cham F; Choudhary A; Rybak SM; Fouts T; Montefiori DC; Broder CC; Quinnan GV; Dimitrov DS
Virology; 2007 Jun; 363(1):79-90. PubMed ID: 17306322
[TBL] [Abstract][Full Text] [Related]
4. Discovery of a human monoclonal antibody that cross-neutralizes venom phospholipase A
Sørensen CV; Almeida JR; Bohn MF; Rivera-de-Torre E; Schoffelen S; Voldborg BG; Ljungars A; Vaiyapuri S; Laustsen AH
Toxicon; 2023 Oct; 234():107307. PubMed ID: 37783315
[TBL] [Abstract][Full Text] [Related]
5. Discovery and optimization of a broadly-neutralizing human monoclonal antibody against long-chain α-neurotoxins from snakes.
Ledsgaard L; Wade J; Jenkins TP; Boddum K; Oganesyan I; Harrison JA; Villar P; Leah RA; Zenobi R; Schoffelen S; Voldborg B; Ljungars A; McCafferty J; Lomonte B; Gutiérrez JM; Laustsen AH; Karatt-Vellatt A
Nat Commun; 2023 Feb; 14(1):682. PubMed ID: 36755049
[TBL] [Abstract][Full Text] [Related]
6. Immunological profile of antivenoms: preclinical analysis of the efficacy of a polyspecific antivenom through antivenomics and neutralization assays.
Gutiérrez JM; Lomonte B; Sanz L; Calvete JJ; Pla D
J Proteomics; 2014 Jun; 105():340-50. PubMed ID: 24583507
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody.
Zhang MY; Xiao X; Sidorov IA; Choudhry V; Cham F; Zhang PF; Bouma P; Zwick M; Choudhary A; Montefiori DC; Broder CC; Burton DR; Quinnan GV; Dimitrov DS
J Virol; 2004 Sep; 78(17):9233-42. PubMed ID: 15308718
[TBL] [Abstract][Full Text] [Related]
8. Broadly cross-reactive HIV neutralizing human monoclonal antibody Fab selected by sequential antigen panning of a phage display library.
Zhang MY; Shu Y; Phogat S; Xiao X; Cham F; Bouma P; Choudhary A; Feng YR; Sanz I; Rybak S; Broder CC; Quinnan GV; Evans T; Dimitrov DS
J Immunol Methods; 2003 Dec; 283(1-2):17-25. PubMed ID: 14659896
[TBL] [Abstract][Full Text] [Related]
9. Isolation of human monoclonal antibodies that neutralize human rotavirus.
Higo-Moriguchi K; Akahori Y; Iba Y; Kurosawa Y; Taniguchi K
J Virol; 2004 Apr; 78(7):3325-32. PubMed ID: 15016854
[TBL] [Abstract][Full Text] [Related]
10. History of Envenoming Therapy and Current Perspectives.
Pucca MB; Cerni FA; Janke R; Bermúdez-Méndez E; Ledsgaard L; Barbosa JE; Laustsen AH
Front Immunol; 2019; 10():1598. PubMed ID: 31354735
[TBL] [Abstract][Full Text] [Related]
11. Pathology-specific experimental antivenoms for haemotoxic snakebite: The impact of immunogen diversity on the in vitro cross-reactivity and in vivo neutralisation of geographically diverse snake venoms.
Alomran N; Alsolaiss J; Albulescu LO; Crittenden E; Harrison RA; Ainsworth S; Casewell NR
PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009659. PubMed ID: 34407084
[TBL] [Abstract][Full Text] [Related]
12. Discovery of broadly-neutralizing antibodies against brown recluse spider and Gadim scorpion sphingomyelinases using consensus toxins as antigens.
Rivera-de-Torre E; Lampadariou S; Møiniche M; Bohn MF; Kazemi SM; Laustsen AH
Protein Sci; 2024 Mar; 33(3):e4901. PubMed ID: 38358130
[TBL] [Abstract][Full Text] [Related]
13. Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes.
Moulard M; Phogat SK; Shu Y; Labrijn AF; Xiao X; Binley JM; Zhang MY; Sidorov IA; Broder CC; Robinson J; Parren PW; Burton DR; Dimitrov DS
Proc Natl Acad Sci U S A; 2002 May; 99(10):6913-8. PubMed ID: 11997472
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the efficacy of Taiwanese freeze-dried neurotoxic antivenom against Naja kaouthia, Naja siamensis and Ophiophagus hannah through proteomics and animal model approaches.
Liu CC; You CH; Wang PJ; Yu JS; Huang GJ; Liu CH; Hsieh WC; Lin CC
PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006138. PubMed ID: 29244815
[TBL] [Abstract][Full Text] [Related]
15. Biosynthetic Oligoclonal Antivenom (BOA) for Snakebite and Next-Generation Treatments for Snakebite Victims.
Kini RM; Sidhu SS; Laustsen AH
Toxins (Basel); 2018 Dec; 10(12):. PubMed ID: 30551565
[TBL] [Abstract][Full Text] [Related]
16. In Vitro Immunological Cross-Reactivity of Thai Polyvalent and Monovalent Antivenoms with Asian Viper Venoms.
Chaisakul J; Rusmili MRA; Alsolaiss J; Albulescu LO; Harrison RA; Othman I; Casewell NR
Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33287378
[TBL] [Abstract][Full Text] [Related]
17. Protein content of antivenoms and relationship with their immunochemical reactivity and neutralization assays.
de Roodt AR; Clement H; Dolab JA; Litwin S; Hajos SE; Boyer L; Alagón A
Clin Toxicol (Phila); 2014 Jul; 52(6):594-603. PubMed ID: 24940642
[TBL] [Abstract][Full Text] [Related]
18. In vivo neutralization of coral snake venoms with an oligoclonal nanobody mixture in a murine challenge model.
Benard-Valle M; Wouters Y; Ljungars A; Nguyen GTT; Ahmadi S; Ebersole TW; Dahl CH; Guadarrama-Martínez A; Jeppesen F; Eriksen H; Rodríguez-Barrera G; Boddum K; Jenkins TP; Bjørn SP; Schoffelen S; Voldborg BG; Alagón A; Laustsen AH
Nat Commun; 2024 May; 15(1):4310. PubMed ID: 38773068
[TBL] [Abstract][Full Text] [Related]
19. Synthetic development of a broadly neutralizing antibody against snake venom long-chain α-neurotoxins.
Khalek IS; Senji Laxme RR; Nguyen YTK; Khochare S; Patel RN; Woehl J; Smith JM; Saye-Francisco K; Kim Y; Misson Mindrebo L; Tran Q; Kędzior M; Boré E; Limbo O; Verma M; Stanfield RL; Menzies SK; Ainsworth S; Harrison RA; Burton DR; Sok D; Wilson IA; Casewell NR; Sunagar K; Jardine JG
Sci Transl Med; 2024 Feb; 16(735):eadk1867. PubMed ID: 38381847
[TBL] [Abstract][Full Text] [Related]
20. Design of a new therapy to treat snake envenomation.
Shahidi Bonjar L
Drug Des Devel Ther; 2014; 8():819-25. PubMed ID: 24971000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
